The Filing Desk

Enovis vs Revvity

Enovis ENOV · Revvity RVTY · Health Care Equipment

Revvity reported revenue of $2.9 billion in fiscal 2025, 1.3 times Enovis' $2.2 billion in fiscal 2025. Enovis' revenue grew 6.7% in its latest year, and Revvity's grew 3.7%. Enovis had an operating margin of -50.0%, against 12.5% at Revvity. Free cash flow was $20 million at Enovis and $509 million at Revvity. Their fiscal years end in different months (December 31 and December 28), so the periods don't line up exactly.

Side by side

EnovisRevvity
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 28, 2025
Revenue$2.2B$2.9B
Revenue growth6.7%3.7%
Revenue growth a year, last 5 years14.9%−5.5%
Gross margin59.8%—
Operating margin−50.0%12.5%
Net margin−52.7%8.4%
Free cash flow$20M$509M
Free cash flow margin0.9%17.8%
Return on capital−26.9%3.3%
Net debt to EBITDA5.7x3.0x
Dividends and buybacks$4M$854M
Change in diluted share count3.2%−5.1%
Last close$21.16$160.39
P/E at the last close—76.7×
Insider trades, last 12 monthsbought $762,432, sold $45,298sold $6.0 million
Piotroski F-score4 of 95 of 8
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
EnovisRevvity
Operating margin
Percent of revenue
EnovisRevvity
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
EnovisRevvity

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Enovis and Revvity pages.